Rhonda Patrick· PhD
there's been just repeating preclinical evidence that amyloid beta you know is decreased and that you know isothiocyanates and sulforaphane seem to have a positive effect on alzheimer's disease
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there's been just repeating preclinical evidence that amyloid beta you know is decreased and that you know isothiocyanates and sulforaphane seem to have a positive effect on alzheimer's disease
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
things like hdac inhibition histone diacetylase sorry inhibition enhancement of bdnf brain derived neurotropic factor um certainly uh reduction in amyloid beta and um the list the list really goes on and on the things that other people have done i have not been directly involved in that
yeah so this is a case where uh i i need to um give dr patrick's listeners a a data dump of of papers there's a huge amount of literature that you know would be fun to post links to from animal models and and cell culture work